988049603	988049603	CD	B-NP	O
|	|	NN	I-NP	O
HVMMC	HVMMC	NN	I-NP	O
|	|	NN	I-NP	O
93522524	93522524	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9063156	9063156	CD	B-NP	O
|	|	CC	I-NP	O
3/18/2005	3/18/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HYPOTENSION	HYPOTENSION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/18/2005	8/18/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/2/2005	10/2/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
CABANISS	CABANISS	NN	B-NP	O
,	,	,	O	O
ROLF	ROLF	NNP	B-NP	O
L.	L.	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
Hypertension	Hypertension	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
anterior	anterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
graft	graft	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
posterior	posterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
graft	graft	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-VP	O
obtuse	obtuse	VB	I-VP	O
marginal	marginal	JJ	B-NP	O
1	1	CD	I-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Recent	Recent	NNP	B-NP	O
Southjones	Southjones	NNP	I-NP	O
Cheme	Cheme	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	IN	B-PP	O
admission	admission	NN	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
furosemide	furosemide	NN	B-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
torsemide	torsemide	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
percutaneous	percutaneous	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenting	stente	VBG	B-VP	O
with	with	IN	B-PP	O
5	5	CD	B-NP	O
drug-eluting	drug-eluting	JJ	I-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
77-year-old	77-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	B-protein
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
idiopathic	idiopathic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
biventricular	biventricular	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
and	and	CC	I-NP	O
ICD	ICD	NN	I-NP	B-protein
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Tonha	Tonha	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ED	ED	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
monitor	monitor	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
malaise	malaise	NN	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
taking	take	VBG	I-VP	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
stopping	stop	VBG	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Imdur	Imdur	NN	B-NP	O
and	and	CC	I-NP	O
labetalol	labetalol	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
the	the	DT	B-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.8	2.8	CD	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
being	be	VBG	I-VP	O
fatigued	fatigue	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
rotational	rotational	JJ	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
having	have	VBG	I-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
headache	headache	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
urinary	urinary	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
dysuria	dysuria	NN	B-NP	O
or	or	CC	I-NP	O
hematuria	hematuria	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Erythromycin	Erythromycin	NN	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
cephalosporin	cephalosporin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
give	give	VBP	B-VP	O
her	her	PRP	B-NP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Imdur	Imdur	NN	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Labetalol	Labetalol	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
mEq	mEq	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
47	47	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
and	and	CC	O	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
2	2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
125	125	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
consumption	consumption	NN	B-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
or	or	CC	I-NP	O
injection	injection	NN	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Revealed	Reveal	VBD	B-VP	O
a	a	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
at	at	IN	B-PP	O
8	8	CD	B-NP	O
to	to	TO	I-NP	O
9	9	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
.	.	.	O	O

Benign	Benign	JJ	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
.	.	.	O	O

Moist	Moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
rhonchi	rhonchi	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
crackles	crackle	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
exam	exam	NN	I-NP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
rub	rub	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallop	gallop	NN	B-NP	O
was	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
nontender	nontender	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
,	,	,	O	O
obese	obese	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
1	1	CD	B-NP	I-protein
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Pertinent	Pertinent	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
findings	finding	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
36.3	36.3	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7.7	7.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
317	317	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	B-protein
138	138	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-cell_line
102	102	CD	I-NP	I-cell_line
,	,	,	O	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	B-protein
2.8	2.8	CD	I-NP	I-protein
.	.	.	O	O

Glucose	Glucose	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
88	88	CD	B-NP	I-protein
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
coagulopathic	coagulopathic	JJ	B-NP	O
and	and	CC	I-NP	O
normal	normal	JJ	I-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ventricularly	ventricularly	RB	I-VP	O
paced	pace	VBN	I-VP	O
at	at	IN	B-PP	O
54	54	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
from	from	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
pump	pump	NN	I-NP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Imdur	Imdur	NN	I-NP	O
and	and	CC	I-NP	O
labetalol	labetalol	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
renal	renal	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
without	without	IN	B-PP	O
IV	IV	CD	B-NP	O
hydration	hydration	NN	I-NP	O
and	and	CC	I-NP	O
holding	holding	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
p.o.	p.o.	FW	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
returned	return	VBD	B-VP	O
towards	towards	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
value	value	NN	B-NP	O
is	be	VBZ	B-VP	O
2.3	2.3	CD	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
Imdur	Imdur	NNP	I-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
spironolactone	spironolactone	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
put	put	VBD	B-VP	O
out	out	RP	B-PRT	O
over	over	IN	B-NP	O
2	2	CD	I-NP	O
L	L	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
second	second	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
Toprol-XL	Toprol-XL	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
once	once	RB	B-NP	O
daily	daily	JJ	I-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
achieving	achieve	VBG	I-VP	O
good	good	JJ	B-NP	O
forward	forward	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
flow	flow	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
130s	130s	CD	I-NP	B-DNA
to	to	TO	B-PP	I-DNA
150s	150s	CD	B-NP	I-DNA
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
retaining	retain	VBG	I-VP	O
fluid	fluid	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
previous	previous	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
aggressively	aggressively	RB	I-ADJP	O
diuresed	diurese	VBN	I-ADJP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
gain	gain	VB	I-VP	O
weight	weight	NN	B-NP	O
and	and	CC	O	O
retained	retain	VBN	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
dose	dose	NN	I-NP	O
achieving	achieve	VBG	B-VP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
net	net	JJ	B-NP	O
diureses	diures	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	O	O
achieves	achieve	VBZ	B-VP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
and	and	CC	O	O
maintaining	maintain	VBG	B-VP	O
adequate	adequate	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
Lipitor	Lipitor	NN	I-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
doses	dose	NNS	I-NP	O
for	for	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
overnight	overnight	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
irritant	irritant	JJ	B-NP	O
anginal	anginal	JJ	I-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

Imdur	Imdur	NNP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
held	hold	VBN	I-VP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
excessive	excessive	JJ	B-ADJP	O
,	,	,	O	O
currently	currently	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
and	and	CC	O	O
p.r.n.	p.r.n.	VB	B-VP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
and	and	CC	I-NP	O
rate	rate	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ventricularly	ventricularly	RB	I-VP	O
paced	pace	VBN	I-VP	O
and	and	CC	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
at	at	IN	B-PP	O
1.5	1.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
known	know	VBN	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
achieved	achieve	VBD	B-VP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
PT	PT	NN	I-NP	O
at	at	IN	B-PP	O
2.8	2.8	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
or	or	CC	I-NP	O
events	event	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
or	or	CC	I-NP	O
rate	rate	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
by	by	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	FW	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
hypovolemia	hypovolemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
issues	issue	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
aggressive	aggressive	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
,	,	,	O	O
taking	take	VBG	B-VP	O
good	good	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
On	On	NNP	I-NP	O
November	November	NNP	I-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
10/10	10/10	CD	B-NP	O
left	leave	VBD	B-VP	O
flank	flank	JJ	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
associated	associate	VBN	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
lasting	last	VBG	B-VP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
reported	report	VBD	B-VP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
known	know	VBN	B-NP	O
gallstone	gallstone	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
,	,	,	O	O
identified	identify	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
ultrasound	ultrasound	NN	B-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
dislocation	dislocation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
also	also	RB	B-ADVP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	O
colic	colic	JJ	I-NP	O
and	and	CC	O	O
as	as	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
stone	stone	NN	I-NP	O
protocol	protocol	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
kidney	kidney	NN	I-NP	O
stone	stone	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
did	do	VBD	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
once	once	RB	B-ADVP	O
again	again	RB	I-ADVP	O
gallstone	gallstone	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
codeine	codeine	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
by	by	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
known	know	VBN	I-NP	O
biliary	biliary	JJ	I-NP	O
colic	colic	JJ	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
by	by	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
codeine	codeine	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Tylenol	Tylenol	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
650	650	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
IV	IV	CD	B-NP	O
morphine	morphine	NN	I-NP	O
,	,	,	O	O
requesting	request	VBG	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
narcotics	narcotic	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
events	event	NNS	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
47	47	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
fingersticks	fingerstick	NNS	I-NP	O
were	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
70s	70	NNS	I-NP	O
as	as	IN	B-SBAR	O
were	be	VBD	B-VP	O
her	her	PRP$	B-NP	O
p.m.	p.m.	NN	I-NP	O
fingersticks	fingerstick	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
decreased	decrease	VBN	B-NP	O
p.o.	p.o.	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
service	service	NN	I-NP	O
after	after	IN	B-SBAR	O
consultation	consultation	NN	B-NP	O
recommended	recommend	VBD	B-VP	O
decreasing	decrease	VBG	I-VP	O
her	her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
35	35	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
p.m.	p.m.	NN	I-NP	O
insulin	insulin	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
requested	request	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
injections	injection	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
preprandial	preprandial	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
administered	administer	VBN	B-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
express	express	VB	I-VP	O
preference	preference	NN	B-NP	O
for	for	IN	B-PP	O
twice	twice	RB	B-NP	O
daily	daily	JJ	I-NP	O
injections	injection	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
achieved	achieve	VBD	B-VP	O
goal	goal	NN	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
regimen	regimen	NN	B-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
such	such	JJ	B-NP	O
her	her	PRP$	I-NP	O
Synthroid	Synthroid	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
to	to	TO	B-VP	O
repeat	repeat	VB	I-VP	O
her	her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
and	and	CC	I-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
,	,	,	O	O
Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
K-Dur	K-Dur	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
mEq	mEq	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
loss	loss	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diureses	diures	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
over	over	IN	B-PP	O
course	course	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low-cholesterol	low-cholesterol	JJ	I-NP	O
low-fat	low-fat	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
UA	UA	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
concerning	concern	VBG	B-PP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
low-grade	low-grade	JJ	I-NP	O
UTI	UTI	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
presenting	present	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
3-day	3-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
completed	complete	VBN	B-VP	O
this	this	DT	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	B-cell_line
urine	urine	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
only	only	RB	B-NP	O
50	50	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
colony-forming	colony-forming	JJ	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
mixed	mixed	JJ	B-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
remained	remain	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
FOLLOWING	FOLLOWING	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

To	To	TO	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
her	her	PRP$	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
repeat	repeat	VB	I-VP	O
her	her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
level	level	NN	I-NP	O
to	to	TO	B-VP	O
maximize	maximize	VB	I-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
Synthroid	Synthroid	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

To	To	TO	B-VP	O
have	have	VB	I-VP	O
followup	followup	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Polashek	Polashek	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
to	to	TO	B-VP	O
maximize	maximize	VB	I-VP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
ensure	ensure	VB	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
1.5	1.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
35	35	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Sublingual	Sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
0.4-mg	0.4-mg	CD	I-NP	O
tablet	tablet	NN	I-NP	O
1	1	CD	B-NP	O
tablet	tablet	NN	I-NP	O
every	every	DT	B-NP	O
5	5	CD	I-NP	O
minutes	minute	NNS	I-NP	O
x3	x3	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Imdur	Imdur	NN	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
followup	followup	NN	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sam	Sam	NNP	I-NP	O
Rochholz	Rochholz	NNP	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jude	Jude	NNP	I-NP	O
Raheja	Raheja	NNP	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
;	;	:	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
scheduled	schedule	VBN	I-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-8358489	8-8358489	CD	B-NP	O
SSSten	SSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Frank	Frank	NNP	B-NP	O
Harrison	Harrison	NNP	I-NP	O
Kiggins	Kiggins	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Ston	Ston	NNP	I-NP	O
Yonkers	Yonkers	NNP	I-NP	O
Hend	Hend	NNP	I-NP	O
Field	Field	NNP	I-NP	O
T	T	NNP	I-NP	O
,	,	,	O	O
Maine	Maine	NNP	B-NP	O
77830	77830	CD	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Markus	Markus	NNP	B-NP	O
S.	S.	NNP	I-NP	O
Lasso	Lasso	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
SUOHC	SUOHC	NNP	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
Division	Division	NNP	I-NP	O
Ville	Ville	NNP	I-NP	O
Tamp	Tamp	NNP	I-NP	O
Northblo	Northblo	NNP	I-NP	O
Smouthver	Smouthver	NNP	I-NP	O
Au	Au	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SYLVE	SYLVE	NNP	B-NP	O
,	,	,	O	O
THADDEUS	THADDEUS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DUSENBERY	DUSENBERY	NNP	B-NP	O
,	,	,	O	O
WILLARD	WILLARD	NNP	B-NP	O
N.	N.	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4230184	4230184	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/15/05	8/15/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/15/05	8/15/05	CD	B-NP	O

